2-Methyl-3-isopropyl-phenol | 4371-48-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2-Methyl-3-isopropyl-phenol
• 英文别名: 3-Isopropyl-2-methylphenol；2-methyl-3-propan-2-ylphenol
• CAS: 4371-48-6
• 化学式: C₁₀H₁₄O
• 分子量: 150.221
• InChiKey: NKXINWNCBKRRIC-UHFFFAOYSA-N

物化性质

• 熔点：
  46.81°C (estimate)
• 沸点：
  236.65°C (estimate)
• 密度：
  0.9688 (estimate)

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  11
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  20.2
• 氢给体数：
  1
• 氢受体数：
  1

安全信息

• 海关编码：
  2907199090

反应信息

• 作为反应物：
  描述：

  三聚丙烯 、 2-Methyl-3-isopropyl-phenol 在 氢化铝 作用下， 生成 3,6-diisopropyl-2-methylphenol
  参考文献：
  名称：

  Synthesis, biological evaluation, and preliminary structure-activity considerations of a series of alkylphenols as intravenous anesthetic agents

  摘要：

  Following our discovery of the intravenous (iv) anesthetic activity of 2,6-diethylphenol in mice, a series of alkylphenols was examined in this species and the most active analogues were further evaluated in rabbits. The synthesis of compounds which were not commercially available was accomplished by adaptations of standard ortho-alkylation procedures for phenols. Structure-activity relationships were found to be complex, but, in general, potency and kinetics appeared to be a function of both the lipophilic character and the degree of steric hindrance exerted by ortho substituents. The most interesting compounds were found in the 2,6-dialkyl series, and the greatest potency was associated with 2,6-di-sec-alkyl substitution. In particular, 2,6-diisopropylphenol (ICI 35 868) emerged as a candidate for further development and has subsequently been shown to be an effective iv anesthetic agent in man.

  DOI：

  10.1021/jm00186a013
• 作为产物：
  描述：

  2-(3-methoxy-2-methyl-phenyl)-propan-2-ol 在 甲醇 、 copper oxide-chromium oxide 、 氢溴酸 、 溶剂黄146 作用下， 200.0 ℃ 、5.49 MPa 条件下， 生成 2-Methyl-3-isopropyl-phenol
  参考文献：
  名称：

  THE ISOPROPYL CRESOLS

  摘要：

  DOI：

  10.1021/jo01122a001

文献信息

• DERIVATIVE OF NOVEL POLYHYDROXY AROMATIC COMPOUND AND USE THEREOF
  申请人：RNS CO.,LTD.

  公开号：US20150283051A1

  公开（公告）日：2015-10-08

  Provided is a skin whitening composition with excellent whitening effects, specifically, a derivative or a polyhydroxy cyclic compound represented by Formula I or a pharmacologically acceptable salt thereof, comprising; wherein is derived from an aromatic cyclic compound, C n , C n+1 and C n+2 are three neighboring carbon atoms present in the aromatic cyclic compound, wherein n is a positive integer, R 1 and R 2 are each a saturated or unsaturated straight or branched alkyl or acyl group having 3 to 12 carbon atoms, and R 3 , R 4 , R 5 and R 6 are each independently at least one substituent selected from hydrogen, alkyl, alkoxy, acyloxy, acyloxymethyl, oxo, hydroxy, vinyl, nitrile, carboxaldehyde, carbonitrile and aldehyde.

  提供一个具有优异美白效果的皮肤美白组合物，具体为公式I所表示的衍生物或多元醇环化合物或其药理上可接受的盐，其中 所述的芳香族环化合物，C n ，C n+1 和C n+2 是存在于芳香族环化合物中的三个相邻的碳原子，其中n是正整数，R 1 和R 2 分别是具有3至12个碳原子的饱和或不饱和直链或支链烷基或酰基，而R 3 ，R 4 ，R 5 和R 6 各自独立地选自氢、烷基、烷氧基、酰氧基、酰氧甲基、氧代、羟基、乙烯基、腈、羧醛、碳腈和醛中至少一个取代基。
• Raf inhibitor compounds and methods of use thereof
  申请人：Miknis Greg

  公开号：US20070049603A1

  公开（公告）日：2007-03-01

  Compounds of Formula I are useful for inhibiting Raf kinase and for treating disorders mediated thereby. Methods of using compounds of Formula I, and stereoisomers, geometric isomers, tautomers, solvates and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed.

  公式I的化合物对抑制Raf激酶和治疗由此介导的疾病有用。公开了使用公式I的化合物及其立体异构体、几何异构体、互变异构体、溶剂合物和药学上可接受的盐，在哺乳动物细胞中进行体外、体内和体内诊断、预防或治疗此类疾病或相关病理条件的方法。
• [EN] NOVEL ANTIMICROBIAL PEPTIDES AND THEIR APPLICATION<br/>[FR] NOUVEAUX PEPTIDES ANTIMICROBIENS ET LEUR APPLICATION
  申请人：INFINITEC ACTIVOS S L

  公开号：WO2015135896A1

  公开（公告）日：2015-09-17

  The present invention relates to a compound of formula (I) and to compositions comprising said compound, as well as the use of said compound and/or said compositions to prevent fungal and/or bacterial growth.

  本发明涉及式(I)的化合物，以及包含该化合物的组合物，以及使用该化合物和/或所述组合物来防止真菌和/或细菌生长。
• [EN] PREPARATION OF SUBSTITUTED 3-ARYL-5-TRIFLUOROMETHYL-1,2,4-OXADIAZOLES<br/>[FR] PRÉPARATION DE 3-ARYL-5-TRIFLUOROMÉTHYL-1,2,4-OXADIAZOLES SUBSTITUÉS
  申请人：BASF SE

  公开号：WO2019020501A1

  公开（公告）日：2019-01-31

  The present invention relates to a process for the preparation of 3-aryl-5-trifluoromethyl-1,2,4- oxadiazoles, which are useful as fungicidal compounds or as intermediates for the synthesis of fungicidal oxaciazole compounds, using trifluoroacetyl halides.

  本发明涉及一种制备3-芳基-5-三氟甲基-1,2,4-恶二唑的方法，这些恶二唑作为杀真菌化合物或作为合成杀真菌恶二唑化合物的中间体是有用的，使用三氟乙酰卤化物。
• ANTIMICROBIAL AGENT
  申请人：Kanatani Shuji

  公开号：US20150005378A1

  公开（公告）日：2015-01-01

  [Problem] To provide a novel antimicrobial agent that has excellent antimicrobial activity and which is prepared from an ester composed of propanediol and a β-hydroxycarboxylic acid. [Solution] An antimicrobial agent which is prepared from a propanediol mono-β-hydroxycarboxylic acid ester expressed by the following formula (1) or formula (2) (wherein R 1 and R 2 are both branched or unbranched, and saturated or unsaturated alkyl groups having 5 to 9 carbon atoms).

  提供一种新型抗菌剂，具有优异的抗菌活性，由丙二醇和β-羟基羧酸组成的酯制备而成。从以下公式（1）或公式（2）表示的丙二醇单β-羟基羧酸酯制备的抗菌剂（其中R1和R2均为分支或非分支，饱和或不饱和的烷基，具有5至9个碳原子）。